Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 3/20 | 0.39 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.34 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6593145 | 0.84 | XDH (0.40) | XDHSQORADORA1NR4A2 | |
| SCHEMBL6080444 | 0.84 | XDH (0.38) | XDHMAOB | |
| Benzene SCHEMBL6079490 | 0.82 | XDH (0.41) | XDHMAOBMRGPRX4 | |
| SCHEMBL6080482 | 0.81 | XDH (0.40) | XDHMAOB | |
| Benzene SCHEMBL6592619 | 0.79 | XDH (0.39) | XDHMAOBMRGPRX4NR4A2 | |
| SCHEMBL6080724 | 0.73 | MAPT (0.38) | MRGPRX4 | |
| SCHEMBL6079921 | 0.72 | MRGPRX4 (0.41) | ADORA1MRGPRX4 | |
| SCHEMBL6079521 | 0.71 | FOLH1 (0.40) | MRGPRX4 | |
| SCHEMBL6080303 | 0.69 | KDM5B (0.36) | XDHADORA1 | |
| SCHEMBL16719427 | 0.68 | MAOB (0.48) | XDHSQORMAOBNR4A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060183909-A1 | Compositions derived from quinoline and quinoxaline, preparation and use thereof | NEURO3D (FR) | 2006-08-17 | — | — | US | claimed |
| US-20060183909-A1 | Compositions derived from quinoline and quinoxaline, preparation and use thereof | NEURO3D (FR) | 2006-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060183909-A1 | Compositions derived from quinoline and quinoxaline, preparation and use thereof | NQO1, NQO2, RECQL | XDH 128/4885SQOR 16/4885ADORA1 1161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.